跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOLOVANZ 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DOLOVANZ 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
DOLOVANZ 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Laboratorios Cinfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 26, 2023
Approval ID
8ea6cbdb1c04c335
Company
Laboratorios Cinfa S.A.
Type
Standard
Approval Details
Approval Id
8ea6cbdb1c04c335
Drug Cima Aemps Name
DOLOVANZ 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
88869
Holder Company Name
Laboratorios Cinfa S.A.
Marketing Company Name
Laboratorios Cinfa S.A.
Authorization Date
2023-05-26
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
12,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
No
Company Name
Laboratorios Cinfa S.A.
Active Ingredients
DEXKETOPROFENO TROMETAMOL
18,45 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 26, 2023
Approval ID
8ea6cbdb1c04c335
Type
Standard
Back to CIMA-AEMPS Approvals
